# Edgewise Therapeutics, Inc.: Form 8-K, filed May 10, 2024

- Company: [Edgewise Therapeutics, Inc.](/companies/ewtx.md) (CIK 1710072)
- Form: 8-K
- Filed: 2024-05-10
- Accepted by EDGAR: May 10, 2024, 13:10 ET
- Period: 2024-05-10
- Accession: 0001104659-24-059674
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1710072/000110465924059674/tm2413802d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1710072/000110465924059674/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1710072/000110465924059674/tm2413802d2_8k.htm

Filed May 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-059674. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.